Diabetes Worsens Functional Outcomes in Young Female Rats

Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes

Weiguo Li, Rebecca Ward, John Paul Valenzuela, Guangkuo Dong, Susan C. Fagan, Adviye Ergul

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Diabetes worsens stroke outcome and increases the risk of hemorrhagic transformation (HT) after ischemic stroke, especially with tissue plasminogen activator (tPA) treatment. The widespread use of tPA is still limited by the fear of hemorrhagic transformation (HT), and underlying mechanisms are actively being pursued in preclinical studies. However, experimental models use a 10 times higher dose of tPA than the clinical dose (10 mg/kg) and mostly employ only male animals. In this translational study, we hypothesized that low-dose tPA will improve the functional recovery after the embolic stroke in both control and diabetic male and female animals. Diabetes was induced in age-matched male and female Wistar rats with high fat diet and low-dose streptozotocin (30 mg/kg, i.p.). Embolic stroke was induced with clot occlusion of the middle cerebral artery (MCA). The animals were treated with or without tPA (1 mg/kg, i.v.) at 90 min after surgery. An additional set of animals were subjected to 90 min MCAO with suture. Neurological deficits (composite score and adhesive removal test-ART), infarct size, edema ratio, and HT index were assessed 3 days after surgery. In the control groups, female rats had smaller infarcts and better functional outcomes. tPA decreased infarct size in both sexes with a greater effect in males. While there was no difference in HT between males and females without tPA, HT was less in the female + tPA group. In the diabetic groups, neuronal injury increased in females reaching that of the infarct sizes seen in male rats. tPA decreased infarct size in females but not males. HT was greater in female rats than in males and was not further increased with tPA. Diabetes worsened neurological deficits in both sexes. Male animals showed improved sensorimotor skills, especially with tPA treatment, but there was no improvement in females. These data suggest that diabetes amplifies neurovascular injury and neurological deficits in both sexes. Human dose tPA offers some degree of protection in male but not female rats. Given that control female animals experience less injury compared to male rats, the diabetes effect is more profound in females.

Original languageEnglish (US)
Pages (from-to)429-439
Number of pages11
JournalTranslational Stroke Research
Volume8
Issue number5
DOIs
StatePublished - Oct 1 2017

Fingerprint

Tissue Plasminogen Activator
Stroke
Wounds and Injuries
Middle Cerebral Artery Infarction
High Fat Diet
Streptozocin
Adhesives
Sutures
Fear
Wistar Rats
Edema
Theoretical Models

Keywords

  • Cerebral ischemia
  • Embolic stroke
  • Female
  • Hemorrhagic transformation
  • Sex differences
  • Type 2 diabetes
  • tPA

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Diabetes Worsens Functional Outcomes in Young Female Rats : Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes. / Li, Weiguo; Ward, Rebecca; Valenzuela, John Paul; Dong, Guangkuo; Fagan, Susan C.; Ergul, Adviye.

In: Translational Stroke Research, Vol. 8, No. 5, 01.10.2017, p. 429-439.

Research output: Contribution to journalArticle

Li, Weiguo ; Ward, Rebecca ; Valenzuela, John Paul ; Dong, Guangkuo ; Fagan, Susan C. ; Ergul, Adviye. / Diabetes Worsens Functional Outcomes in Young Female Rats : Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes. In: Translational Stroke Research. 2017 ; Vol. 8, No. 5. pp. 429-439.
@article{a8c974633ad949688016a997d712cd38,
title = "Diabetes Worsens Functional Outcomes in Young Female Rats: Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes",
abstract = "Diabetes worsens stroke outcome and increases the risk of hemorrhagic transformation (HT) after ischemic stroke, especially with tissue plasminogen activator (tPA) treatment. The widespread use of tPA is still limited by the fear of hemorrhagic transformation (HT), and underlying mechanisms are actively being pursued in preclinical studies. However, experimental models use a 10 times higher dose of tPA than the clinical dose (10 mg/kg) and mostly employ only male animals. In this translational study, we hypothesized that low-dose tPA will improve the functional recovery after the embolic stroke in both control and diabetic male and female animals. Diabetes was induced in age-matched male and female Wistar rats with high fat diet and low-dose streptozotocin (30 mg/kg, i.p.). Embolic stroke was induced with clot occlusion of the middle cerebral artery (MCA). The animals were treated with or without tPA (1 mg/kg, i.v.) at 90 min after surgery. An additional set of animals were subjected to 90 min MCAO with suture. Neurological deficits (composite score and adhesive removal test-ART), infarct size, edema ratio, and HT index were assessed 3 days after surgery. In the control groups, female rats had smaller infarcts and better functional outcomes. tPA decreased infarct size in both sexes with a greater effect in males. While there was no difference in HT between males and females without tPA, HT was less in the female + tPA group. In the diabetic groups, neuronal injury increased in females reaching that of the infarct sizes seen in male rats. tPA decreased infarct size in females but not males. HT was greater in female rats than in males and was not further increased with tPA. Diabetes worsened neurological deficits in both sexes. Male animals showed improved sensorimotor skills, especially with tPA treatment, but there was no improvement in females. These data suggest that diabetes amplifies neurovascular injury and neurological deficits in both sexes. Human dose tPA offers some degree of protection in male but not female rats. Given that control female animals experience less injury compared to male rats, the diabetes effect is more profound in females.",
keywords = "Cerebral ischemia, Embolic stroke, Female, Hemorrhagic transformation, Sex differences, Type 2 diabetes, tPA",
author = "Weiguo Li and Rebecca Ward and Valenzuela, {John Paul} and Guangkuo Dong and Fagan, {Susan C.} and Adviye Ergul",
year = "2017",
month = "10",
day = "1",
doi = "10.1007/s12975-017-0525-7",
language = "English (US)",
volume = "8",
pages = "429--439",
journal = "Translational Stroke Research",
issn = "1868-4483",
publisher = "Springer US",
number = "5",

}

TY - JOUR

T1 - Diabetes Worsens Functional Outcomes in Young Female Rats

T2 - Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes

AU - Li, Weiguo

AU - Ward, Rebecca

AU - Valenzuela, John Paul

AU - Dong, Guangkuo

AU - Fagan, Susan C.

AU - Ergul, Adviye

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Diabetes worsens stroke outcome and increases the risk of hemorrhagic transformation (HT) after ischemic stroke, especially with tissue plasminogen activator (tPA) treatment. The widespread use of tPA is still limited by the fear of hemorrhagic transformation (HT), and underlying mechanisms are actively being pursued in preclinical studies. However, experimental models use a 10 times higher dose of tPA than the clinical dose (10 mg/kg) and mostly employ only male animals. In this translational study, we hypothesized that low-dose tPA will improve the functional recovery after the embolic stroke in both control and diabetic male and female animals. Diabetes was induced in age-matched male and female Wistar rats with high fat diet and low-dose streptozotocin (30 mg/kg, i.p.). Embolic stroke was induced with clot occlusion of the middle cerebral artery (MCA). The animals were treated with or without tPA (1 mg/kg, i.v.) at 90 min after surgery. An additional set of animals were subjected to 90 min MCAO with suture. Neurological deficits (composite score and adhesive removal test-ART), infarct size, edema ratio, and HT index were assessed 3 days after surgery. In the control groups, female rats had smaller infarcts and better functional outcomes. tPA decreased infarct size in both sexes with a greater effect in males. While there was no difference in HT between males and females without tPA, HT was less in the female + tPA group. In the diabetic groups, neuronal injury increased in females reaching that of the infarct sizes seen in male rats. tPA decreased infarct size in females but not males. HT was greater in female rats than in males and was not further increased with tPA. Diabetes worsened neurological deficits in both sexes. Male animals showed improved sensorimotor skills, especially with tPA treatment, but there was no improvement in females. These data suggest that diabetes amplifies neurovascular injury and neurological deficits in both sexes. Human dose tPA offers some degree of protection in male but not female rats. Given that control female animals experience less injury compared to male rats, the diabetes effect is more profound in females.

AB - Diabetes worsens stroke outcome and increases the risk of hemorrhagic transformation (HT) after ischemic stroke, especially with tissue plasminogen activator (tPA) treatment. The widespread use of tPA is still limited by the fear of hemorrhagic transformation (HT), and underlying mechanisms are actively being pursued in preclinical studies. However, experimental models use a 10 times higher dose of tPA than the clinical dose (10 mg/kg) and mostly employ only male animals. In this translational study, we hypothesized that low-dose tPA will improve the functional recovery after the embolic stroke in both control and diabetic male and female animals. Diabetes was induced in age-matched male and female Wistar rats with high fat diet and low-dose streptozotocin (30 mg/kg, i.p.). Embolic stroke was induced with clot occlusion of the middle cerebral artery (MCA). The animals were treated with or without tPA (1 mg/kg, i.v.) at 90 min after surgery. An additional set of animals were subjected to 90 min MCAO with suture. Neurological deficits (composite score and adhesive removal test-ART), infarct size, edema ratio, and HT index were assessed 3 days after surgery. In the control groups, female rats had smaller infarcts and better functional outcomes. tPA decreased infarct size in both sexes with a greater effect in males. While there was no difference in HT between males and females without tPA, HT was less in the female + tPA group. In the diabetic groups, neuronal injury increased in females reaching that of the infarct sizes seen in male rats. tPA decreased infarct size in females but not males. HT was greater in female rats than in males and was not further increased with tPA. Diabetes worsened neurological deficits in both sexes. Male animals showed improved sensorimotor skills, especially with tPA treatment, but there was no improvement in females. These data suggest that diabetes amplifies neurovascular injury and neurological deficits in both sexes. Human dose tPA offers some degree of protection in male but not female rats. Given that control female animals experience less injury compared to male rats, the diabetes effect is more profound in females.

KW - Cerebral ischemia

KW - Embolic stroke

KW - Female

KW - Hemorrhagic transformation

KW - Sex differences

KW - Type 2 diabetes

KW - tPA

UR - http://www.scopus.com/inward/record.url?scp=85014047853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014047853&partnerID=8YFLogxK

U2 - 10.1007/s12975-017-0525-7

DO - 10.1007/s12975-017-0525-7

M3 - Article

VL - 8

SP - 429

EP - 439

JO - Translational Stroke Research

JF - Translational Stroke Research

SN - 1868-4483

IS - 5

ER -